PATENT CLAIM ANALYSIS

Application Number: 16189559
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "182000"]

Abstract:
The present invention relates to obeticholic acid: or a pharmaceutically acceptable salt, solvate or amino acid conjugate thereof. Obeticholic acid is useful for the treatment or prevention of a FXR mediated disease or condition, cardiovascular disease or cholestatic liver disease, and for reducing HDL cholesterol, for lowering triglycerides in a mammal, or for inhibition of fibrosis. The present invention also relates to processes for the synthesis of obeticholic acid.

Claim (Index 1):
A tablet comprising a non-crystalline obeticholic acid in the amount of about 1 mg to about 25 mg.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.65957
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14947658', '14947680', '15496398', '14947492', '14979005']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9101635566060458
- 35 USC 102 Novelty (BERT): 0.6568594795678009
- Combined Prediction Score: 0.8848331489022213
- Mean Citation Score: 794.969556
- Max Citation Score: 803.91724
- Similarity Product: 537.4183445029784

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test